Government and private sector must work together on HIV vaccine

NewsGuard 100/100 Score

The success of antiretroviral therapy for HIV/AIDS "has fooled us into believing HIV is under control. It is not. … The fact remains that no sexually acquired infection has ever been controlled in democratic societies except by vaccines," Lawrence Corey, president and director of the Fred Hutchinson Cancer Research Center and principal investigator of the international HIV Vaccine Trials Network, writes in a Wall Street Journal opinion piece.

Just as "government and private science collaborated to eradicate polio in the West" in the 1950s, the efforts to eradicate AIDS "cannot be done by the private sector alone. At a time when our country bitterly debates the role of government in medicine, I know that only the government's participation in a public-private partnership will produce an effective HIV/AIDS vaccine."  He concludes, "To end the reign of HIV/AIDS will require an unparalleled commitment - both intellectual and financial. Yes, there will be setbacks, but there will also be successes. Ultimately, I believe, we will see the end of HIV/AIDS" (6/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The path to a better tuberculosis vaccine runs through Montana